Anna Geraghty
Affiliations: | University of California, Berkeley, Berkeley, CA, United States |
Google:
"Anna Geraghty"Mean distance: 16.48 (cluster 7) | S | N | B | C | P |
Parents
Sign in to add mentor| Daniela Kaufer | research assistant | UC Berkeley | |
| George E. Bentley | grad student | UC Berkeley | |
| Michelle Monje | post-doc | Stanford |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Geraghty AC, Acosta-Alvarez L, Rotiroti M, et al. (2024) Immunotherapy-related cognitive impairment after CAR T cell therapy in mice. Biorxiv : the Preprint Server For Biology |
| Taylor KR, Barron T, Hui A, et al. (2023) Glioma synapses recruit mechanisms of adaptive plasticity. Nature |
| Klein J, Wood J, Jaycox J, et al. (2023) Distinguishing features of Long COVID identified through immune profiling. Nature |
| Mabe NW, Huang M, Dalton GN, et al. (2022) Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1. Nature Cancer |
| Fernández-Castañeda A, Lu P, Geraghty AC, et al. (2022) Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell |
| Majzner RG, Ramakrishna S, Yeom KW, et al. (2022) GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature |
| Fernández-Castañeda A, Lu P, Geraghty AC, et al. (2022) Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. Biorxiv : the Preprint Server For Biology |
| Theruvath J, Menard M, Smith BAH, et al. (2022) Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nature Medicine |
| Steadman PE, Xia F, Ahmed M, et al. (2019) Disruption of Oligodendrogenesis Impairs Memory Consolidation in Adult Mice. Neuron |
| Lin GL, Wilson KM, Ceribelli M, et al. (2019) Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Science Translational Medicine. 11 |